8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001213900-26-063125
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea0292693-8k_moonlake.htm…